| Product Name | MF | CAS | Details |
|---|
| 2-Chloro-4,5-dimethylbenzo[d]thiazole | C9H8ClNS | 252681-54-2 | Details |
| [Ala17]-MCH | C97H155N29O26S4 | 359784-84-2 | Details |
| H-NSLFEYQK^-OH | Details |
| 9-Ethyl-9H-carbazole-3,6-dicarbaldehyde | C16H13NO2 | 70207-46-4 | Details |
| 1-(1H-Indazol-5-yl)ethan-1-amine | C9H11N3 | 1001906-62-2 | Details |
| [1-Methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]methanol | C6H7F3N2O | 949898-58-2 | Details |
| 2,2-Difluoro-2-[4-(trifluoromethyl)phenyl]acetic acid | C9H5F5O2 | 73790-11-1 | Details |
| 1-[2-(Pyrrolidin-1-yl)ethyl]-1H-pyrazole-4-carboxylic acid | C10H15N3O2 | 1155065-00-1 | Details |
| 4-Chloro-3-nitro-5-sulfamoylbenzoic acid | C7H5ClN2O6S | 22892-96-2 | Details |
| H-VSVFVPPR-OH | Details |
| 2-Amino-3-[4-(dihydroxyboranyl)-2-fluorophenyl]propanoic acid | C9H11BFNO4 | 292050-22-7 | Details |
| Notoginsenoside T1 | C36H60O10 | 343962-53-8 | Details |
| H-SSLPFQNI-OH | Details |
| N-Phenylpiperidine-4-carboxamide | C12H16N2O | 73415-85-7 | Details |
| Methyl 5-amino-2-chloropyridine-3-carboxylate | C7H7ClN2O2 | 886435-73-0 | Details |
| ±-Amylcinnamaldehyde | C14H18O | 122-40-7 | Details |
| p57 Kip2 antibody (Thr310) | Details |
| Ethyl 2,2-difluoro-3-methylbut-3-enoate | C7H10F2O2 | 1936641-34-7 | Details |
| tert-Butyl 6-amino-1,4-thiazepane-4-carboxylate 1,1-dioxide | C10H20N2O4S | 1369503-78-5 | Details |
| N-(1-Amino-3,3-dimethylbutan-2-yl)-3-methoxyaniline | C13H22N2O | 1489008-67-4 | Details |
| 5-(4-Fluorophenyl)-1,3-oxazole-2-thiol | C9H6FNOS | 923218-69-3 | Details |
| CTNNA3 antibody | Details |
| LRRC49 Blocking Peptide | Details |
| 1-(1,2-Dimethyl-1H-1,3-benzodiazol-6-yl)ethan-1-one | C11H12N2O | 908100-64-1 | Details |
| 1-(3,3,3-Trifluoropropyl)-1H-pyrazole-5-carboxylic acid | C7H7F3N2O2 | 1245772-05-7 | Details |
| tert-Butyl 2-(3,4-dihydro-2H-pyran-5-yl)-2-oxoacetate | C11H16O4 | 1432680-06-2 | Details |
| (E)-3-[3'-(4'-fluorophenyl)-1'-(1'-methylethyl)-1H-indol-2'-yl]-2-propnal | C20H18FNO | 93957-50-7 | Details |
| Boc-2-chloro-L-phenylalanine | C14H18ClNO4 | 114873-02-8 | Details |
| 1-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethan-1-amine hydrochloride | C5H7ClF3N3O | 1909337-88-7 | Details |
| PTDSS1 Blocking Peptide | Details |
| 2-Chloro-N-(1-phenylbutyl)acetamide | C12H16ClNO | 40023-34-5 | Details |
| CDYL2 Blocking Peptide | Details |
| 4,4' -Dihydroxy-3,3'-biphenyldicarboxylic acid | C14H10O6 | 13987-45-6 | Details |
| Besilesomab | 537694-98-7 | Details |
| Methyl 1-methyl-1,2,3,4-tetrahydronaphthalene-1-carboxylate | C13H16O2 | 113967-23-0 | Details |
| 1-(Prop-2-en-1-yl)cyclopentane-1-carboxylic acid | C9H14O2 | 411238-08-9 | Details |
| 2-Chloro-N-[4-(4-ethylphenyl)-1,3-thiazol-2-yl]-2-phenylacetamide | C19H17ClN2OS | 565166-64-5 | Details |
| 3-Methyl-1-(pyridin-2-ylmethyl)piperazine dihydrochloride | C11H18ClN3 | 1803580-63-3 | Details |
| H-DTEEEDFHVDQVTTVK^-OH | Details |
| p62 antibody (C-terminal) | Details |
| H-GEYLPLLQGK-OH | Details |
| 2,4,6-Tris(propan-2-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)benzene-1-sulfonamide | C24H42N2O2S | 300574-86-1 | Details |
| 2-Nitrophenyl 2-acetamido-2-deoxy-a-D-galactopyranoside | C14H18N2O8 | 23646-67-5 | Details |
| H-VYVEELKPTPEGDLEILLQK^-OH | Details |
| 2'-Deoxy-5'-O-DMT-N2-(4-isopropylphenoxyacetyl)guanosine | C42H43N5O8 | 909415-65-2 | Details |
| Chalcone | C15H12O | 94-41-7 | Details |
| 3-[(1,3-Dioxo-2,3-dihydro-1H-isoindol-2-yl)methyl]-1-methyl-1H-pyrazole-4-carboxylic acid | C14H11N3O4 | 1801270-07-4 | Details |
| (R)-Apremilast | C22H24N2O7S | 608141-44-2 | Details |
| CYMAL-6 neopentyl glycol | C47H84O22 | Details |
| MAP1S antibody (FITC) | Details |
| N-Cbz-L-valine | C13H17NO4 | 1149-26-4 | Details |
| SARS-CoV-2 NSP7 (1-15) | Details |
| 1-(2-(1-bromo(2-naphthyloxy))acetyl)-4-phenyl-3-thiosemicarbazide | C19H16BrN3O2S | 349469-29-0 | Details |
| [2-(4-Fluorophenoxy)ethyl](2-methoxyethyl)amine | C11H16FNO2 | 420098-40-4 | Details |
| 2,2-Dimethyl-3-(4-nitrophenyl)cyclobutan-1-one | C12H13NO3 | 1271911-39-7 | Details |
| 6'-Fluoro-3',4'-dihydro-1'H-spiro[cyclobutane-1,2'-quinoxaline]-3'-one | C11H11FN2O | 1503582-73-7 | Details |
| 7-(tert-Butoxycarbonyl)-1-oxa-7-azaspiro[4.4]nonane-2-carboxylic acid | C13H21NO5 | 1268520-63-3 | Details |
| [1-(2,2-Dimethylmorpholin-4-yl)cyclohexyl]methanamine | C13H26N2O | 1155544-20-9 | Details |
| N-Nitrosopiperidine-d10 | C5H10N2O | 960049-21-2 | Details |
| 2-Amino-N-[(2-chlorophenyl)methyl]-4,5-dimethylbenzene-1-sulfonamide | C15H17ClN2O2S | 1036616-28-0 | Details |
| 3H,4H,6H,7H-Pyrano[3,4-d]imidazole-2-carbaldehyde | C7H8N2O2 | 1341086-36-9 | Details |
| (2Z)-2-(Hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.4]non-3-ene | C13H12O2 | 4575-53-5 | Details |
| ALG13 antibody | Details |
| Myelin Basic Protein (87-99) (human, bovine, rat) | C74H114N20O17 | 118506-26-6 | Details |
| 2-Hydroxy-5-[(2-methoxyphenyl)sulfamoyl]benzoic acid | C14H13NO6S | 262282-50-8 | Details |
| 2-Cycloheptyl-2-hydroxyacetic acid | C9H16O3 | 18537-84-3 | Details |
| 5-Iodofuran-2-carboxylic acid | C5H3IO3 | 18614-11-4 | Details |
| Protein 4E-BP1 (initiation factor eIF-4-binding protein 1) (human) | 185703-54-2 | Details |
| 2-Fluoro-4-(4-fluorophenyl)phenol | C12H8F2O | 168158-52-9 | Details |
| 2-Chloronaphthalen-1-ol | C10H7ClO | 606-40-6 | Details |
| 4-[(tert-Butoxy)carbonyl]-2-(prop-2-en-1-yl)morpholine-2-carboxylic acid | C13H21NO5 | 1823994-60-0 | Details |
| 4-(4-Difluoromethoxy-phenyl)-thiazol-2-ylamine | C10H8F2N2OS | 105512-78-5 | Details |
| 3-Chloro-6-fluoropyridin-2-amine | C5H4ClFN2 | 1232431-23-0 | Details |
| Methyl 2-acetamido-4-O-(2-acetamido-2-deoxy-b-D-glucopyranosyl)-2-deoxy-6-O-(a-L-fucopyranosyl)-b-D-glucopyranoside | C23H40N2O15 | 97242-84-7 | Details |
| Ferritin ELISA kit | Details |
| 1-Aminopropane-2-sulfonamide hydrochloride | C3H11ClN2O2S | 1420660-61-2 | Details |
| MRAS antibody | Details |
| Bisabolol oxide B | C15H26O2 | 26184-88-3 | Details |
| 1,3-Dimethyl 2-(chloromethylidene)propanedioate | C6H7ClO4 | 38238-77-6 | Details |
| 1-Isocyanato-3-(propan-2-yl)benzene | C10H11NO | 55304-09-1 | Details |
| 3,4-Diethoxybenzene-1-sulfonamide | C10H15NO4S | 104296-87-9 | Details |
| 5-Methyl-1-(oxolan-3-yl)-1H-1,2,3-triazole-4-carboxylic acid | C8H11N3O3 | 1342071-49-1 | Details |
| 3'-Ethoxyacetanilide | C10H13NO2 | 591-33-3 | Details |
| (-)-Zeylenol | C21H20O7 | 78804-17-8 | Details |
| 2,2,2-Trifluoroethyl pyridine-3-carboxylate hydrochloride | C8H7ClF3NO2 | 1803587-60-1 | Details |
| (2R)-1-Benzoylpyrrolidine-2-carboxylic acid | C12H13NO3 | 115795-02-3 | Details |
| 2-(Iodomethyl)-oxepane | C7H13IO | 130868-43-8 | Details |
| N,N'-Dimethyl-2-nitro-1,1-ethendiamine | C4H9N3O2 | 54252-45-8 | Details |
| Zalutumumab | 667901-13-5 | Details |
| anti-E.coli O157 Antibody Monoclonal | Details |
| 5-(Methoxycarbonyl)thieno[2,3-b]thiophene-2-carboxylic acid | C9H6O4S2 | 2225136-06-9 | Details |
| 3-ethyl-5-((3-phenoxyphenyl)methylene)-2-thioxo-1,3-thiazolidin-4-one | C18H15NO2S2 | 359899-51-7 | Details |
| 6-Isopropoxynicotinic acid | C9H11NO3 | 223127-05-7 | Details |
| ASPHD2 antibody | Details |
| Ethyl 2-(thian-4-yl)acetate | C9H16O2S | 218624-29-4 | Details |
| 4-Chloro-3-nitrobenzylamine hydrochloride | C7H8Cl2N2O2 | 116599-39-4 | Details |
| 4-Chloro-3,5-bis(difluoromethyl)-1H-pyrazole | C5H3ClF4N2 | 1092769-15-7 | Details |
| 1-(2-Methoxyethyl)-6-oxo-1,6-dihydropyridine-3-carboxylic acid | C9H11NO4 | 1234914-99-8 | Details |
| 5-(tert-Butylamino)-N'-hydroxypyridine-2-carboximidamide | C10H16N4O | 1443987-56-1 | Details |
| Cis-3-(tert-butoxycarbonyl)cyclobutanecarboxylic acid | C10H16O4 | 1212288-54-4 | Details |
| Product Total： Product Page： | ||||
| 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 | ||||